List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 18 studies with search of: cysteamine
Hide studies that are not seeking new volunteers.
Hide studies with unknown recruitment status.
  Display Options
Rank Status Study
1 Completed Pilot Study of Safety, Tolerability, Pharmacokinetics/Pharmacodynamics (PK/PD) of RP103 Compared to Cystagon® in Patients With Cystinosis
Condition: Cystinosis
Interventions: Drug: Cystagon® (Cysteamine Bitartrate) Capsules: 150 mg/50 mg;   Drug: RP103
2 Active, not recruiting Phase 3 Study of Cysteamine Bitartrate Delayed-release (RP103) Compared to Cystagon® in Patients With Cystinosis
Condition: Cystinosis
Interventions: Drug: Cystagon® (Cysteamine Bitartrate);   Drug: Cysteamine Bitartrate Delayed-release Capsules (RP103)
3 Not yet recruiting Cysteamine Bitartrate Delayed-Release for the Treatment of NAFLD in Children
Condition: Nonalcoholic Fatty Liver Disease (NAFLD)
Interventions: Drug: delayed release cysteamine bitartrate;   Other: DR cysteamine bitartrate placebo
4 Recruiting An Open Trial of Cysteamine Treatment in Schizophrenia
Conditions: Schizophrenia;   Schizoaffective
Intervention: Drug: Cysteamine
5 Terminated
Has Results 		Cysteamine Therapy for Major Depressive Disorder
Condition: Major Depressive Disorder
Intervention: Drug: cysteamine bitartrate
6 Active, not recruiting Study in Healthy Adults to Determine the Effect That Food Has on the Absorption and Delivery of the Drug Cystagon™
Conditions: Cystinosis;   Nephropathic Cystinosis
Intervention: Drug: Cysteamine bitartrate
7 Completed A Phase II/III Study of Cysteamine (Mercaptoethylamine) and Zidovudine for the Treatment of HIV Disease
Condition: HIV Infections
Interventions: Drug: Cysteamine;   Drug: Zidovudine
8 Recruiting Cysteamine Eye Drops to Treat Corneal Crystals in Cystinosis
Condition: Cystinosis
Intervention: Drug: Cysteamine
9 Completed New Cysteamine Eye Drops Formulation to Treat Corneal Crystals in Cystinosis
Condition: Cystinosis
Intervention: Drug: Cysteamine
10 Recruiting Long-Term Safety Follow-up Study of Cysteamine Bitartrate Delayed-release Capsules (RP103)
Condition: Cystinosis
Intervention: Drug: Cysteamine Bitartrate Delayed-release Capsules (RP103)
11 Recruiting Use of Cysteamine in the Treatment of Cystinosis
Condition: Cystinosis
Intervention: Drug: Cysteamine
12 Unknown † A Preliminary Study to Evaluate Cysteamine Therapy in Human Subjects With Non-Alcoholic Steatohepatitis (NASH)
Condition: Fatty Liver
Intervention: Drug: Cysteamine
13 Active, not recruiting Cystagon to Treat Infantile Neuronal Ceroid Lipofuscinosis
Condition: Infantile Neronal Ceroid Lipofuscinosis
Intervention: Drug: Cystagon
14 Completed Randomized Study of New Formulation Ophthalmic Cysteamine Hydrochloride for Corneal Cystine Accumulation in Patients With Cystinosis
Condition: Cystinosis
Intervention: Drug: cysteamine hydrochloride
15 Active, not recruiting Kidney Transplantation in Patients With Cystinosis
Condition: Cystinosis
Intervention:
16 Active, not recruiting Beta Alethine in Treating Patients With Low-Grade Lymphoma
Condition: Lymphoma
Intervention: Drug: beta alethine
17 Unknown † Beta Alethine in Treating Patients With Myeloma
Conditions: Multiple Myeloma and Plasma Cell Neoplasm;   Precancerous Condition
Intervention: Drug: beta alethine
18 Unknown † Beta Alethine in Treating Patients With Waldenstrom's Macroglobulinemia
Condition: Lymphoma
Intervention: Drug: beta alethine

† Indicates status has not been verified in more than two years
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services